Bartlett & Co Wealth Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
VCM
VPM
Bartlett & Co Wealth Management's IDXX Position: Q1 2026 in Review
Bartlett & Co Wealth Management increased its Idexx Laboratories (IDXX) stake by 0.47% in Q1 2026, buying an estimated $641 and bringing the position to 212 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #536.
Bartlett & Co Wealth Management first reported a position in IDXX in Q3 2019 and has held it in 26 quarters since. The position peaked at $200K in Q4 2020. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Bartlett & Co Wealth Management held 212 shares of Idexx Laboratories worth $119K as of Q1 2026.
- Bartlett & Co Wealth Management bought 1 Idexx Laboratories share in Q1 2026, an estimated $641.
- Idexx Laboratories made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q1 2026, its #536 holding.
- Bartlett & Co Wealth Management first reported a position in Idexx Laboratories in Q3 2019 and has held it in 26 quarters since.
- Bartlett & Co Wealth Management's Idexx Laboratories position peaked at $200K in Q4 2020.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Bartlett & Co Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.